Herman Sanchez - 27 Jun 2025 Form 4 Insider Report for Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Reporting relationship: Director
Issuer ticker: HRGN
Reported as of: 27 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2025, 14:00:36 UTC
Prior SEC filing: 15 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Joseph Damasio, by power of attorney

Key filing fact

Herman Sanchez filed Form 4 for Harvard Apparatus Regenerative Technology, Inc. (HRGN) on 01 Jul 2025.

Key facts

This page summarizes Herman Sanchez's Form 4 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 01 Jul 2025, 14:00.

Change

Previous filing in this sequence was filed on 15 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001843559 Primary reporting owner

Sanchez Herman

Relationship: Director
Address: C/O HREGEN, 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON
Signature: /s/ Joseph Damasio, by power of attorney
Signature date: 01 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +18,590
Change %
Price: $0.000000
Shares after: 18,590
Date: 27 Jun 2025
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount: 18,590
Exercise price: $1.60
Footnotes: F1

HRGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +15,227
Change %
Price: $0.000000
Shares after: 15,227
Date: 27 Jun 2025
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount: 15,227
Exercise price: $1.60
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026.

Footnote F2

This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025.

SEC remarks

This form has been signed under power of attorney.